MoonLake Immunotherapeutics (MLTX) income statement
MLTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$11.07+0.04 (+0.36%)
Close on Nov 20, 2026Market cap $942.13MP/E –Yield –
MoonLake Immunotherapeutics financial ratios
See a number that looks wrong?